Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

Inclusion Criteria:

Male and females greater than or equal to 18 years of age
Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS)
Prescribed BETASERON (note: decision to treat with BETASERON must be made independent of participation in this study)
Confirmation of insurance coverage for BETASERON treatment
Access to a personal computer to complete online patient satisfaction survey at Week 6

Exclusion Criteria:

Currently enrolled in a clinical trial or other observational study for Multiple Sclerosis treatment
Documented substance abuse within the previous 6 months prior to study enrollment
Any major laboratory value abnormality that the investigator believes would preclude the patient from participating in the study
Any medical disorder, condition or history that in the opinion of the investigator would impair the patient's ability to participate in or complete the study
Pregnant or nursing